mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |